JDRF’s mission is to find a cure for diabetes through the support of research. JDRF is also committed to developing new and better treatments that improve the lives of people with type-one diabetes in the near term and keep them healthy while advancing toward a cure.
Dedicated to Finding a Cure
The Juvenile Diabetes Research Foundation International (JDRF) is the worldwide leader in funding research to cure type-one diabetes, an autoimmune disease that strikes children and adults suddenly and lasts a lifetime. JDRF is the leading funder and advocate of type 1 diabetes science.
JDRF’s mission has been constant since it was founded four decades ago: to find a cure for type-one diabetes through the support of research. Until a cure is found, JDRF is also committed to working tirelessly to develop new and better treatments to improve the lives of people who have type-one diabetes and keep them as healthy as possible.
Today, people with type-one diabetes rely on insulin to manage the disease. But insulin is not a cure, nor does it prevent the possibility of the disease’s devastating effects, which can include kidney failure, blindness, heart disease, stroke, amputation, and pregnancy complications. JDRF is dedicated to finding a cure for type-one diabetes and removing the burdens and threats that the disease carries.
A Global Leader in Type-one Diabetes Research
Many important developments in type-one diabetes research have resulted from JDRF funding, as well as its many partnerships and public awareness efforts. JDRF funds more type-one diabetes research worldwide than any other charity. JDRF directed nearly $107 million to such research in FY2010, bringing its total research funding to more than $1.5 billion since its founding in 1970.
To ensure that it supports science with the greatest potential to produce results as soon as possible, the people who decide where to focus JDRF’s research funding includes leading scientists from around the world, JDRF’s team of scientists, as well as people who either have type-one diabetes themselves or have family members with the disease.
Improving Lives Today and in the Future
JDRF-funded research encompasses type-one diabetes at every life- stage: stopping or slowing its progression in people who are newly diagnosed; reversing it in those who have lived with the disease for years; avoiding or reversing complications; and preventing the disease in people at risk and in future generations. Areas of focus include developing immune therapies, replacing and regenerating beta cells, achieving tight glucose control, and stopping or reversing complications.
JDRF funding and leadership goes well beyond basic research. JDRF supports and exploits scientific discoveries and translates them into solutions, such as therapies and devices that can tangibly benefit people with diabetes today. In FY2010, JDRF funded more than 40 human clinical trials, several of which are in the advanced stages of clinical testing needed before government approvals are required.
Efficiently Organized for Successful Results
JDRF is structured on a business-world model that efficiently and effectively directs resources to research aimed at finding a cure and developing new treatments as soon as possible. More than 80 percent of JDRF’s expenditures directly support research and research-related education. JDRF leverages its impact by partnering with academic institutions, governments, biotechnology and pharmaceutical companies, other disease organizations and foundations, and people with type-one diabetes.
A Backbone of Dedicated and Active Volunteers
JDRF was founded in 1970 by parents of children with type-one diabetes. Today, volunteers at JDRF’s more than 100 locations worldwide remain the driving force behind the Foundation’s success in advancing research toward a cure. Because of their personal connection to type-one diabetes, JDRF’s volunteers have a passionate and unrelenting commitment to the JDRF mission.